Literature DB >> 2429977

Significance of the Ro antigen system.

M Reichlin.   

Abstract

Knowledge about antibodies to the Ro/SSA and La/SSB antigens has expanded greatly. Recognition of these antibodies was probably achieved 25 years ago but their macromolecular structure, clinical associations, and genetic relationships have come to light only in the past 7 years. It seems clear that these antibodies have a special place in the nosology of SLE and SS and that in certain instances (e.g., neonatal LE) the antibodies play a direct pathogenic role, while in other circumstances (e.g., vasculitis, nephritis, SS) tissue damage might result from immune complex deposition on vascular structures. Certainly, the latter problems will be active areas of investigation in the coming years. If the pace of recent progress continues, many of the questions raised in this review should soon have clear answers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429977     DOI: 10.1007/BF00915372

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  59 in total

1.  Lacrimal and salivary precipitating antibodies in Sjögren's syndrome.

Authors:  B R JONES
Journal:  Lancet       Date:  1958-10-11       Impact factor: 79.321

2.  Association between the Ro and La antigenic determinants: immunodiffusion analysis of human spleen extract.

Authors:  R A Eisenberg
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

3.  Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.

Authors:  E L Alexander; F C Arnett; T T Provost; M B Stevens
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

4.  Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies.

Authors:  T T Provost; F C Arnett; M Reichlin
Journal:  Arthritis Rheum       Date:  1983-10

5.  Serological findings in patients with "ANA-negative" systemic lupus erythematosus.

Authors:  P J Maddison; T T Provost; M Reichlin
Journal:  Medicine (Baltimore)       Date:  1981-03       Impact factor: 1.889

6.  Antibodies to SS-B in chronic inflammatory connective tissue diseases. Relationship with HLA-Dw2 and HLA-Dw3 antigens in primary Sjögren's syndrome.

Authors:  R Manthorpe; A M Teppo; G Bendixen; O Wegelius
Journal:  Arthritis Rheum       Date:  1982-06

7.  Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets.

Authors:  M C Hochberg; R E Boyd; J M Ahearn; F C Arnett; W B Bias; T T Provost; M B Stevens
Journal:  Medicine (Baltimore)       Date:  1985-09       Impact factor: 1.889

8.  Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies.

Authors:  O Meyer; G Hauptmann; G Tappeiner; H D Ochs; F Mascart-Lemone
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

9.  Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens.

Authors:  D A Bell; P J Maddison
Journal:  Arthritis Rheum       Date:  1980-11

10.  Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome.

Authors:  J B Harley; M Reichlin; F C Arnett; E L Alexander; W B Bias; T T Provost
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

View more
  24 in total

1.  IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein.

Authors:  S Barakat; O Meyer; F Torterotot; P Youinou; J P Briand; M F Kahn; S Muller
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

2.  The ultrastructural localization of 60-kDa Ro protein and human cytoplasmic RNAs: association with novel electron-dense bodies.

Authors:  A D Farris; F Puvion-Dutilleul; E Puvion; J B Harley; L A Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

3.  Defective selection of thymic regulatory T cells accompanies autoimmunity and pulmonary infiltrates in Tcra-deficient mice double transgenic for human La/Sjögren's syndrome-B and human La-specific TCR.

Authors:  Jane C Yaciuk; Yujun Pan; Karen Schwarz; Zi-Jian Pan; Jacen S Maier-Moore; Stanley D Kosanke; Christina Lawrence; A Darise Farris
Journal:  J Immunol       Date:  2015-01-12       Impact factor: 5.422

4.  Characterization of human telomerase complex.

Authors:  S Ramakrishnan; H W Sharma; A D Farris; K M Kaufman; J B Harley; K Collins; G J Pruijn; W J van Venrooij; M L Martin; R Narayanan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

5.  Sera from some patients with antibody-associated paraneoplastic encephalomyelitis/sensory neuronopathy recognize the Ro-52K antigen.

Authors:  G Manley; E Wong; J Dalmau; K Elkon; J Posner; H Furneaux
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Calreticulin synthetic peptide analogues: anti-peptide antibodies in autoimmune rheumatic diseases.

Authors:  J G Routsias; A G Tzioufas; M Sakarellos-Daitsiotis; C Sakarellos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

7.  Mapping of the human 60,000 M(r) Ro/SSA locus: the genes for three Ro/SSA autoantigens are located on separate chromosomes.

Authors:  M B Frank; M G Mattei
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

8.  La/SSB ribonucleoprotein levels increased in transformed cells.

Authors:  R P Rother; P S Thomas
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

9.  Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein.

Authors:  B Bozic; G J Pruijn; B Rozman; W J van Venrooij
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

10.  The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms.

Authors:  M B Frank; K Itoh; A Fujisaku; P Pontarotti; M G Mattei; B R Neas
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.